TherapeuticsMD
TXMD
TXMD
114 hedge funds and large institutions have $716M invested in TherapeuticsMD in 2015 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 50 increasing their positions, 36 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
114
Holders Change
-1
Holders Change %
-0.87%
% of All Funds
3.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
50
Reduced
36
Closed
15
Calls
$19.8M
Puts
$3.27M
Net Calls
+$16.6M
Net Calls Change
+$6.91M
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
+$28.7M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$16.8M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$14M |
| 4 |
Bank of New York Mellon
New York
|
+$5.69M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.69M |
Top Sellers
| 1 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$11.6M |
| 2 |
Millennium Management
New York
|
-$3.56M |
| 3 |
BCM
Barometer Capital Management
Toronto,
Ontario, Canada
|
-$3.34M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$3.14M |
| 5 |
Morgan Stanley
New York
|
-$2.37M |
